Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
12 Nov 2026Primus PharmaceuticalsUnited StatesEffect of Metaxalone 640 mg (M640) on Driving, Cognition, and EEG Dynamics Compared to Tizanidine 8 mg in AdultsPhase 4Not Yet Recruiting12 Nov 2026Qilu Pharmaceutical Co., Ltd.ChinaPhase Ib/II Clinical Study of QLS5133 Combination Therapy in Advanced Solid TumorsPhase 1, Phase 2Not Yet Recruiting12 Nov 2026Qilu Pharmaceutical Co., Ltd.A Study in Participants With Relapsed or Refractory Multiple Myeloma for QLS4131Phase 3Not Yet Recruiting12 Nov 2026Regeneron PharmaceuticalsStudy to Evaluate ALN-CIDEB in Adults With Fibrotic Alcohol-Associated Liver Disease (ALD)Phase 2Not Yet Recruiting12 Nov 2026Revision SkincareUnited StatesA Case Study to Assess a Brightening Skincare Regimen in Patients With Bothersome Skin Dark SpotsNot applicableCompleted12 Nov 2026SanofiA Study to Investigate Long-term Safety and Tolerability of Frexalimab in Participants With Multiple SclerosisPhase 3Not Yet Recruiting12 Nov 2026Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.ChinaA Phase I of FXS0260 in Advanced Solid TumorPhase 1Not Yet Recruiting12 Nov 2026Shattuck Labs, Inc.A Study of SL-325 in Participants With Hidradenitis SuppurativaPhase 2Not Yet Recruiting12 Nov 2026Sinfatin S.LSpainRimonabant for Cognitive Impairment in People With Post-COVID-19 SyndromePhase 2Not Yet Recruiting12 Nov 2026SinocareReal-time CGM in Perioperative Glycemic ManagementNot applicableNot Yet Recruiting12 Nov 2026Suzhou Ribo Life Science Co. Ltd.Phase I Trial of RBD4059 in Chinese Healthy ParticipantsPhase 1Not Yet Recruiting12 Nov 2026SWIMS America Corp.United StatesCombined TECAR/EMS Therapy vs. Standard Manual Therapy for Endometriosis Pelvic PainNot applicableRecruiting12 Nov 2026Telix Pharmaceuticals (Innovations) Pty Limited[18F]FET PET for Differentiating Tumor Progression vs Treatment-Related Changes in Brain MetastasesPhase 3Not Yet Recruiting12 Nov 2026Toby, Inc.A Study of Urine Volatile Organic Compounds for Disease DetectionNot Yet Recruiting12 Nov 2026Txinno Bioscience Inc.South KoreaPhase 1b/2 to Evaluate the Safety, Tolerability, and Efficacy of TXN10128 in Combination With TOPO-I Inhibitor-based Therapies (Irinotecan or TROP2 ADC) in Advanced or Metastatic EGFR Mutated NSCLCPhase 1, Phase 2Recruiting12 Nov 2026Whanin Pharmaceutical CompanyA Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of WIF-2402 in Healthy AdultsPhase 1Not Yet Recruiting12 Nov 2026YGION Biomedical GmbHAustriaFirst Study Evaluating the Safety and Dosage of YG-01 in Patients With GlioblastomaPhase 1Not Yet Recruiting10 Nov 2026Beijing Inno Medicine Co., Ltd.United States, ChinaA Phase I Clinical Study of YN003 in the Treatment of GliomaPhase 1Recruiting10 Nov 2026Beijing Supreme Life Pharmaceutical Technology Co., Ltd.ChinaFuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Inadequate Glycemic Control on Metformin TherapyPhase 2Not Yet Recruiting10 Nov 2026Boehringer IngelheimBelgium, France, GermanyA Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With ObrixtamigPhase 3Not Yet Recruiting10 Nov 2026CareDxHistoMap AlloSure Renal Biopsies Observational Research StudyNot Yet Recruiting10 Nov 2026Corza Medical GmbHUnited StatesEffectiveness and Safety of TachoSil® Fibrin Sealant Patch for Supporting Dural Sealing Among Adult InpatientsRecruiting10 Nov 2026Eli Lilly and CompanyUnited States, Bulgaria, HungaryA Study of Brenipatide in Participants With Major Depressive DisorderPhase 2Not Yet Recruiting10 Nov 2026Eli Lilly and CompanyUnited StatesA Study of LY3981314 in Participants With Autoimmune HepatitisPhase 1Not Yet Recruiting10 Nov 2026Eli Lilly and CompanyUnited States, France, JapanA Study of LY4336619 in Adult Participants With Advanced Solid TumorsPhase 1Not Yet Recruiting10 Nov 2026Genrix (Shanghai) Biopharmaceutical Co., Ltd.A Clinical Trial of Multiple Doses of GR2301 Injection in Participants With Vitiligo.Phase 2Not Yet Recruiting10 Nov 2026Hangzhou Sciwind Biosciences Co., Ltd.ChinaA Study to Evaluate the Safety and Efficacy of Ecnoglutide Tablets in Chinese Participants With Overweight or ObesityPhase 2Not Yet Recruiting10 Nov 2026HK inno.N CorporationSouth KoreaObservational Study to Evaluate the Safety and Efficacy of Kremezin IDT/Fine Gran in Progressive Chronic Kidney Disease Patients.Recruiting10 Nov 2026ISTx, LLCA Study of Ceftobiprole Compared With Standard Antibiotic Treatment in Children With Staphylococcus Aureus Bacteremia (SAB) Infection, Including Right-sided Heart InfectionPhase 3Not Yet Recruiting10 Nov 2026Kanglin Biotechnology (Hangzhou) Co., Ltd.United StatesA Phase 1/2a Clinical Study of KL002 in Treatment of Parkinson's DiseasePhase 1, Phase 2Not Yet Recruiting10 Nov 2026Kura Oncology, Inc.Bioavailability and Bioequivalence Study of Ziftomenib in Participants With Relapsed/Refractory AML or MDSPhase 1Not Yet Recruiting10 Nov 2026MedicureUnited States, AustraliaContinuation Study With Oral MC-1 for Treatment of Patients With PNPO-DeficiencyPhase 3Recruiting10 Nov 2026Minghui Pharmaceutical (Shanghai) LTDChinaA Clinical Study of MHB034C for Injection in Participants With Advanced Solid TumorsPhase 1, Phase 2Not Yet Recruiting10 Nov 2026MipSalus ApsDenmarkA First-in-Human Study of Phelimin in Healthy Volunteers and Adults With PKUPhase 1Not Yet Recruiting10 Nov 2026Neuralink CorpUnited StatesAn Early Feasibility Study of a Robotically Implanted Brain-Computer Interface for Neural Control of External Devices in Spinal Cord Injury, Amyotrophic Lateral Sclerosis, and Chronic Ischemic StrokeNot applicableRecruiting10 Nov 2026Novartis PharmaceuticalsA Study of Real-world Effectiveness of 177Lu-PSMA-617 With and Without Concurrent Androgen Receptor Pathway Inhibitors in Metastatic Castration Resistant Prostate Cancer PatientsNot Yet Recruiting10 Nov 2026Peach PerfectUnited StatesA Clinical Trial to Evaluate the Effects of a Supplement on Gut HealthNot applicableRecruiting10 Nov 2026Polisorb Joint Stock CompanyRussiaEfficacy and Safety of Polisorb® MP in the Complex Therapy of Patients With Atopic DermatitisPhase 3Completed10 Nov 2026PT Bio FarmaIndonesiaCy-Tb for Detecting Mycobacterium Tuberculosis Infection in Indonesian PopulationNot applicableNot Yet Recruiting10 Nov 2026Qilu Pharmaceutical Co., Ltd.A Phase II Clinical Trial to Evaluate the Efficacy and Safety of QLS1410 Tablets in Patients With Uncontrolled Hypertension Who Are Receiving One or More Background Drug TreatmentsPhase 2Not Yet Recruiting10 Nov 2026Reselute, Inc.United StatesLocal Antibiotic Delivery From an Intramedullary Nail After Surgical Treatment of Tibial Fractures at High Risk of InfectionNot applicableNot Yet Recruiting10 Nov 2026Resurge Therapeutics Inc.RELEASE Ph2 RT-310 BPH StudyPhase 2Not Yet Recruiting10 Nov 2026SanofiThe Efficacy and Safety of Venglustat Compared With Cerezyme in Pediatric Participants 2 to 11 Years of Age With Gaucher Disease Type 3 (GD3)Phase 3Not Yet Recruiting10 Nov 2026SATO Pharmaceutical Co., Ltd.United StatesSafety and Efficacy Study of SKX-16 in Participants With Mild to Moderate Distal Subungual OnychomycosisPhase 2Not Yet Recruiting10 Nov 2026Shenzhen NewDEL Biotech, Co., LtdChinaA Phase Ⅱa Study of ND-003 Tablets in Patients With Idiopathic Pulmonary FibrosisPhase 2Enrolling By Invitation10 Nov 2026Stealth BioTherapeutics Inc.Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Subcutaneous Injections of Elamipretide in Pediatric Subjects With Barth SyndromePhase 1Not Yet Recruiting10 Nov 2026SuisselleFranceEffectiveness and Safety of Cellbooster Glow in Healthy SubjectsNot applicableNot Yet Recruiting10 Nov 2026SuisselleFranceEffectiveness and Safety of Cellbooster Hair in Healthy SubjectsNot applicableNot Yet Recruiting10 Nov 2026TripleMed B.V.NetherlandsSafety and Effectiveness Assessment of AneuFix Injectable Polymer Sac Filling to Assure Long-term Durability of EVAR.Not applicableNot Yet Recruiting10 Nov 2026Vigonvita Life SciencesChinaStudy of Food Effects of VV261 Tablets in Healthy Trial ParticipantsPhase 1Not Yet Recruiting// How AOS uses this